Molecular Markers of Chemotherapy Toxicity in Colorectal Cancer

被引：2
|
作者：
Braun, Michael S. [1 ]
Seymour, Matthew T. [1 ]
机构：
[1] Univ Leeds, Leeds Inst Mol Med, Sect Oncol & Clin Res, Leeds, W Yorkshire, England
来源：
CURRENT COLORECTAL CANCER REPORTS | 2011年 / 7卷 / 01期
关键词：
Fluorouracil; Irinotecan; Oxaliplatin; Pharmacogenomics; Toxicity; Colorectal;
D O I：
10.1007/s11888-010-0078-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Personalized medicine appears to be the inevitable consequence of improvements in our understanding of the mechanisms of action of chemotherapeutic agents, as well as the description of the human genome and its impact on our understanding of the genes involved in DNA repair and drug metabolism. These rapid developments have been associated with the first efforts to establish genetic predictors of chemotherapy efficacy and toxicity for the chemotherapy drugs active in colorectal cancer-fluorouracil, irinotecan, and oxaliplatin.
引用
收藏
页码：105 / 111
页数：7
相关论文
共 50 条
  • [31] Molecular Markers and Chemotherapy for Advanced Salivary Cancer
    Vander Poorten V.
    Meulemans J.
    Delaere P.
    Nuyts S.
    Clement P.
    Current Otorhinolaryngology Reports, 2014, 2 (2) : 85 - 96
  • [32] Molecular Markers in the Treatment of Metastatic Colorectal Cancer
    Wilson, Peter M.
    LaBonte, Melissa J.
    Lenz, Heinz-Josef
    CANCER JOURNAL, 2010, 16 (03): : 262 - 272
  • [33] Molecular Predictors of Response to Chemotherapy in Colorectal Cancer
    Dienstmann, Rodrigo
    Vilar, Eduardo
    Tabernero, Josep
    CANCER JOURNAL, 2011, 17 (02): : 114 - 126
  • [34] Influence of molecular markers on oncological surgery of colorectal cancer
    Noepel-Duennebacke, Stefanie
    Conradi, Lena-Christin
    Reinacher-Schick, Anke
    Ghadimi, Michael
    CHIRURG, 2021, 92 (11): : 986 - 995
  • [35] Using Molecular Markers to Guide Colorectal Cancer Therapy
    O'Neil, Bert
    ONCOLOGIST, 2012, 17 : 5 - 5
  • [36] CANCER MARKERS IN PATIENTS RECEIVING CHEMOTHERAPY FOR COLORECTAL CANCER - PRELIMINARY-REPORT
    BULLEN, BR
    COOPER, EH
    TURNER, R
    NEVILLE, AM
    GILES, GR
    HALL, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1977, 3 (03): : 289 - 300
  • [37] The use of molecular markers in the diagnosis and treatment of colorectal cancer
    Tejpar, Sabine
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2007, 21 (06) : 1071 - 1087
  • [38] The role of molecular markers in the adjuvant treatment of colorectal cancer
    Allen, WL
    Johnston, PG
    EJC SUPPLEMENTS, 2005, 3 (03): : 263 - 274
  • [39] Molecular prognostic markers and colorectal cancer: The search goes on
    Chung, DC
    GASTROENTEROLOGY, 1998, 114 (06) : 1330 - 1332
  • [40] The Use of Molecular Markers in the Diagnosis of Colorectal Cancer Screening
    Schmid, Gerald
    DIGESTIVE DISEASES, 2010, 28 (4-5) : 625 - 628
12345